Select to order medicines [Delhi/NCR /Bangalore /Chennai /Bhubaneswar /Mumbai]
Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
There are no controlled studies in breastfeeding women, however the risk of untoward effects to a breastfed infant is possible; or, controlled studies show only minimal non-threatening adverse effects. Drugs should be given only if the potential benefit justifies the potential risk to the infant.
Typical usage: URTI including pharyngitis and tonsilitis. Acute exacerbation of chronic bronchitis: Acute community acquired pneumonia: Acute uncomplicated gonorrhoea. Uncomplicated urinary tract infection. Skin infections.
Side Effects: Hemolytic anemia, eosinophilia, lymphocytosis, bone marrow depression, anaphylactic shock, pseudomembranous colitis, intravascular coagulation, dizziness, fatigue, vomiting, anorexia, diarrhea, dyspnea, chills, urticaria.
Drug Interaction: Cefpodoxime is known to interact with other drugs like aluminium hydroxide and oxide, probenecid, propantheline (Br), sodium bicarbonate. These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Mechanism Of Action: The bactericidal activity of cefpodoxime results from its inhibition of cell wall synthesis. The active metabolite of cefpodoxime binds preferentially to penicillin binding protein 3, which inhibits production of peptidoglycan, the primary constituent of bacterial cell walls.
No substitutes found